Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
2016; American Association for the Advancement of Science; Volume: 8; Issue: 344 Linguagem: Inglês
10.1126/scitranslmed.aad8278
ISSN1946-6242
AutoresJohanna F. Dekkers, Gitte Berkers, Evelien Kruisselbrink, Annelotte M. Vonk, Hugo R. de Jonge, Hettie M. Janssens, Inez Bronsveld, E.A. van de Graaf, Edward E. S. Nieuwenhuis, Roderick H.J. Houwen, Frank P. Vleggaar, Johanna C. Escher, Yolanda B. de Rijke, Christof J. Majoor, Harry Heijerman, Karin M. de Winter–de Groot, Hans Clevers, Cornelis K. van der Ent, Jeffrey M. Beekman,
Tópico(s)Asthma and respiratory diseases
ResumoRectal organoids from subjects with cystic fibrosis can be used to assess responses to drugs that modulate CFTR.
Referência(s)